Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$7.98 -8.06%
Market Cap
$661.6M
Price Target
Refer to Report
Volume
1.5M
52wk Range
$2.48 - $15.1
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.